Futuras estrategias terapéuticas en el tratamiento del cáncer de mama metastásico RE+/HER2-negativo: inhibidores CDK4/6 - page 9

Regulation of the cell cycle: role of cyclin-CDK
complexes
G2
S
M
G1
G0
CDK4/6
Cyclin
D1/D2/D3
CDK2
Cyclin A
CDK2
Cyclin E
CDK1
Cyclin A
CDK1
Cyclin B
1,2,3,4,5,6,7,8 10,11,12,13,14,15,16,17,18,19,...40
Powered by FlippingBook